{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:59:58Z","timestamp":1791928798992,"version":"4.3.4"},"reference-count":39,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2022,7,13]]},"DOI":"10.1167\/iovs.63.8.14","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T09:30:59Z","timestamp":1657704659000},"page":"14","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy of an Anti-Semaphorin 3A Neutralizing Antibody in a Male Experimental Retinal Vein Occlusion Mouse Model"],"prefix":"10.1167","volume":"63","author":[{"given":"Shinsuke","family":"Nakamura","sequence":"first","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anri","family":"Nishinaka","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Shimazawa","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Thomas","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and der Ri\u00df, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remko A.","family":"Bakker","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach and der Ri\u00df, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.ophtha.2010.01.060","article-title":"Natural history of central retinal vein occlusion: an evidence-based systematic review","volume":"117","author":"McIntosh","year":"2010","journal-title":"Ophthalmology"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.ophtha.2010.01.058","article-title":"Natural history of branch retinal vein occlusion: an evidence-based systematic review","volume":"117","author":"Rogers","year":"2010","journal-title":"Ophthalmology"},{"key":"bib3","first-page":"OP34","article-title":"Macular edema\u2013an overlooked complication of diabetic retinopathy","volume":"77","author":"Patz","year":"1973","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1167\/iovs.10-7142","article-title":"Focal macular electroretinogram in macular edema secondary to central retinal vein occlusion","volume":"52","author":"Ogino","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ajo.2011.05.028","article-title":"Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography","volume":"152","author":"Sugar","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"920713","DOI":"10.1155\/2013\/920713","article-title":"Structural changes in individual retinal layers in diabetic macular edema","volume":"2013","author":"Murakami","year":"2013","journal-title":"J Diabetes Res"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1084\/jem.174.5.1275","article-title":"Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels","volume":"174","author":"Dvorak","year":"1991","journal-title":"J Exp Med"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ajo.2005.03.003","article-title":"Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6","volume":"140","author":"Noma","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.oret.2018.11.011","article-title":"Distribution of OCT features within areas of macular atrophy or scar after 2 years of anti-VEGF treatment for neovascular AMD in CATT","volume":"3","author":"Toth","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/IJG.0000000000001382","article-title":"Effects of intravitreal anti-VEGF therapy on glaucoma-like progression in susceptible eyes","volume":"28","author":"Du","year":"2019","journal-title":"J Glaucoma"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/IAE.0000000000001685","article-title":"Progressive retinal detachment in infants with retinopathy of prematurity treated with intravitreal bevacizumab or ranibizumab","volume":"38","author":"Yonekawa","year":"2018","journal-title":"Retina"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.1167\/iovs.11-8143","article-title":"Evaluation of macular function using focal macular electroretinography in eyes with macular edema associated with branch retinal vein occlusion","volume":"52","author":"Ogino","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/0896-6273(95)90333-X","article-title":"Semaphorin III can function as a selective chemorepellent to pattern sensory projections in the spinal cord","volume":"14","author":"Messersmith","year":"1995","journal-title":"Neuron"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neuron.2011.06.041","article-title":"Semaphorin3A regulates neuronal polarization by suppressing axon formation and promoting dendrite growth","volume":"71","author":"Shelly","year":"2011","journal-title":"Neuron"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1126\/science.705349","article-title":"Origin of the retina from both sides of the embryonic brain: a contribution to the problem of crossing at the optic chiasma","volume":"202","author":"Jacobson","year":"1978","journal-title":"Science"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000265300","article-title":"Evolution of the pineal complex: correlation of structure and function","volume":"16","author":"Oksche","year":"1984","journal-title":"Ophthalmic Res"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuroscience.2009.03.045","article-title":"Anatomical origins of ocular dominance in mouse primary visual cortex","volume":"161","author":"Coleman","year":"2009","journal-title":"Neuroscience"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.tins.2011.07.001","article-title":"Intrinsically photosensitive retinal ganglion cells: many subtypes, diverse functions","volume":"34","author":"Schmidt","year":"2011","journal-title":"Trends Neurosci"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1167\/iovs.16-21075","article-title":"Sema3A reduces sprouting of adult rod photoreceptors in vitro","volume":"58","author":"Kung","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib22","first-page":"722","article-title":"MicroRNA-30b regulates the polarity of retinal ganglion cells by inhibiting semaphorin-3A","volume":"25","author":"Chan-Juan","year":"2019","journal-title":"Mol Vis"},{"key":"bib23","first-page":"233","article-title":"Neuropilin-1 mediates collapsin-1\/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165","volume":"146","author":"Miao","year":"1999","journal-title":"J Cell Biol"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/aos.2019.97.issue-3","article-title":"Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion","volume":"97","author":"Guo","year":"2019","journal-title":"Acta Ophthalmol"},{"key":"bib25","first-page":"1160","article-title":"In vitro and in vivo studies of BI-X: a humanised Sema3A antibody","volume":"62","author":"Thomas","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1095\/biolreprod42.4.649","article-title":"Genetic influences on the timing of puberty in mice","volume":"42","author":"Nelson","year":"1990","journal-title":"Biol Reprod"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.bbrc.2015.01.052","article-title":"17\u00df-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phase","volume":"457","author":"Zhang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1167\/iovs.18-23994","article-title":"Pathophysiological role of VEGF on retinal edema and nonperfused areas in mouse eyes with retinal vein occlusion","volume":"59","author":"Nishinaka","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"43509","DOI":"10.1038\/srep43509","article-title":"A pharmacological approach in newly established retinal vein occlusion model","volume":"7","author":"Fuma","year":"2017","journal-title":"Sci Rep"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cmet.2013.09.003","article-title":"Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1","volume":"18","author":"Cerani","year":"2013","journal-title":"Cell Metab"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1254\/jphs.08R25FM","article-title":"New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: the regulatory mechanisms of cardiac innervation and their critical roles in cardiac performance","volume":"109","author":"Ieda","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbrc.2007.12.103","article-title":"Sustained up-regulation of semaphorin 3A, Neuropilin1, and doublecortin expression in ischemic mouse brain during long-term recovery","volume":"367","author":"Hou","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"9908","DOI":"10.1074\/jbc.M109.080689","article-title":"Neuropilin 1 directly interacts with Fer kinase to mediate semaphorin 3A-induced death of cortical neurons","volume":"285","author":"Jiang","year":"2010","journal-title":"J Biol Chem"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"49799","DOI":"10.1074\/jbc.M204793200","article-title":"Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy","volume":"277","author":"Shirvan","year":"2002","journal-title":"J Biol Chem"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"15584","DOI":"10.1038\/s41598-017-15682-1","article-title":"The Semaphorin 3A inhibitor SM-345431 preserves corneal nerve and epithelial integrity in a murine dry eye model","volume":"7","author":"Yamazaki","year":"2017","journal-title":"Sci Rep"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"32633","DOI":"10.1074\/jbc.M400642200","article-title":"Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling","volume":"279","author":"Banno","year":"2004","journal-title":"J Biol Chem"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"17762","DOI":"10.1016\/S0021-9258(17)46770-6","article-title":"Tumor necrosis factor-alpha (TNF-alpha) signal transduction through ceramide. Dissociation of growth inhibitory effects of TNF-alpha from activation of nuclear factor-kappa B","volume":"268","author":"Dbaibo","year":"1993","journal-title":"J Biol Chem"},{"key":"bib39","first-page":"1787","article-title":"TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes","volume":"42","author":"Tezel","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib26","article-title":"HORNBILL: A study to test different doses of BI 764524 in patients who have had laser treatment for a type of diabetic eye disease called diabetic retinopathy with diabetic macular ischemia","author":"NCT04424290"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2783472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:31Z","timestamp":1791927091000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2783472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,7,8]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.63.8.14","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}